Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer

BACKGROUND: Phosphoglycerate kinase-1 (PGK1) has been recently documented in various malignancies; however, the molecular mechanisms of the variable PGK1 expression and its clinical significance in terms of survival status remain unclear. METHODS: Real-time quantitative PCR (real-time qPCR) and west...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Sun, S, Liang, X, Zhang, X, Liu, T, Shi, Q, Song, Y, Jiang, Y, Wu, H, Lu, X, Pang, D
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402453/
https://ncbi.nlm.nih.gov/pubmed/25867275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados